GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organon Pharma Indonesia PT (ISX:SCPI) » Definitions » EPS (Basic)

Organon Pharma Indonesia PT (ISX:SCPI) EPS (Basic) : Rp (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Organon Pharma Indonesia PT EPS (Basic)?

Organon Pharma Indonesia PT's basic earnings per share (Basic EPS) for the three months ended in . 20 was Rp0.00. Organon Pharma Indonesia PT does not have enough years/quarters to calculate its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in . 20.

Organon Pharma Indonesia PT's EPS (Diluted) for the three months ended in . 20 was Rp0.00. Organon Pharma Indonesia PT does not have enough years/quarters to calculate its EPS (Diluted) for the trailing twelve months (TTM) ended in . 20.

Organon Pharma Indonesia PT's EPS without NRI for the three months ended in . 20 was Rp0.00. Organon Pharma Indonesia PT does not have enough years/quarters to calculate its EPS without NRI for the trailing twelve months (TTM) ended in . 20.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.


Organon Pharma Indonesia PT EPS (Basic) Historical Data

The historical data trend for Organon Pharma Indonesia PT's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organon Pharma Indonesia PT EPS (Basic) Chart

Organon Pharma Indonesia PT Annual Data
Trend
EPS (Basic)

Organon Pharma Indonesia PT Quarterly Data
EPS (Basic)

Organon Pharma Indonesia PT EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Organon Pharma Indonesia PT's Basic EPS for the fiscal year that ended in . 20 is calculated as


Organon Pharma Indonesia PT's Basic EPS for the quarter that ended in . 20 is calculated as


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organon Pharma Indonesia PT  (ISX:SCPI) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Organon Pharma Indonesia PT EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Organon Pharma Indonesia PT's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Pharma Indonesia PT (ISX:SCPI) Business Description

Traded in Other Exchanges
N/A
Address
Jalan Jend Sudirman Kav 21, Sinarmas MSIG Tower, Floor 37 Unit 102 & 106, South Jakarta, IDN, 12920
Organon Pharma Indonesia PT engages in the development, manufacture, and distribution of pharmaceutical products. It operates through manufacturing and commercial segments. Manufacturing, which generates the majority of the revenue, is engaged in pharmaceutical manufacturing.

Organon Pharma Indonesia PT (ISX:SCPI) Headlines

No Headlines